Search our Innovation Portfolio

Length of Stay(LoS) is driven by the timely delivery of diagnosis and treatment. Where diagnosis or treatment is delayed, LoS and Patient Flow can be severely impacted. In-hopsital respiratory patient events Respiratory Compromise(RC) can increase LoS by 7 days at a cost rate £11,700 with over 55% of events occurring in acute care patients. Respiratory rate(RR) is the earliest indicator of deterioration,giving>24Hours notification of deterioration.PMD proposes to develop a suite of digital interfaces to enable integrate between PMD's respiratory product and hospitals' Electronic Medical Record systems so that it can be leveraged to improve patient flow through timely discharge.

Based on a clinically validated biological assay this project will test a prototype point of care device for use in close proximity of a patient. The assay detects abnormal blood chemistry due to bacterial sepsis, within minutes of sampling and before standard physiological sepsis is diagnosed and has been shown in children and adults in settings that include post-surgery, oncology, acute medical and intensive care units. It has been designed to frequently monitor progression of symptoms with a view to improve overall antibiotic stewardship to collectively meet objectives of the Department of Health “UK Five Year Antimicrobial Resistance Strategy 2013-2018.